Brendan Strong

Brendan Strong

Investor Relations Contact chez KARYOPHARM THERAPEUTICS INC.
Finance
Consumer Services
Health Services

Profil

Brendan Twohig Strong is currently Senior Vice President-Investor Relations at Karyopharm Therapeutics, Inc. since 2024.
Formerly, Mr. Strong was Managing Director at Argot Partners LLC from 2021 to 2024.
Mr. Strong worked as Chief Financial Officer-Massachusetts Market at Tenet Healthcare Corp.
from 2019 to 2020.
Mr. Strong held the position of Research Associate at Barclays Capital, Inc. from 2008 to 2012 and also worked as a Research Associate at Lehman Brothers, Inc. Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.

Postes actifs de Brendan Strong

SociétésPosteDébut
KARYOPHARM THERAPEUTICS INC. Investor Relations Contact 09/12/2024

Anciens postes connus de Brendan Strong

SociétésPosteFin
Corporate Officer/Principal 01/12/2024
TENET HEALTHCARE CORPORATION Investor Relations Contact 30/11/2019
Analyst-Equity 23/09/2008
Analyst-Equity -
Voir l'expérience en détail de Brendan Strong

Formation de Brendan Strong

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Finance

Health Services

Finance

Consumer Services

Health Technology

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Brendan Strong
🔇